Angiographic and clinical outcomes in recent series
| Study, y | No. Aneurysms | Immediate CO, % | Follow-Up CO, % | Early Follow-Up Angiography | Angiographic Follow-Up, mo | Recurrence Rate, % | Time to Recurrence, mo | No. Rupture (mo after EVT) | Morbidity Rate, % |
|---|---|---|---|---|---|---|---|---|---|
| Present series | 400 | 9.5 | 67.4 | DSA at 6 mo | 32 ± 20 | 9.5 | 7.8 ± 5.0 | 1 (2) | 1 |
| Wang et al, 201310 | 142 | 43.7 | 63.4 | DSA < 12 mo | 13.41 ± 2.64 | 12.5 | 9.89 ± 5.21 | 1 (2) | 0 |
| D'Urso et al, 201215 | 126 | 38 | 62 | MRA or DSA | 31.9 ± 28.4 | 17 | – | 0 | 0.8 |
| Sorimachi et al, 201212 | 140 | 33.6 | 55 | DSA at 6 mo | 65.6 ± 37.2 | 11.1 | – | 0 | 0.7 |
| Yadla et al, 201121 | 147 | 68.6 | 64.1 | MRA at 6–12 mo | – | 17.8 | 28.3 | 0 | 1.4 |
| Sun et al, 201111 | 30 | 86.6 | 81.5 | DSA at 3–18 mo | 7.8 | 7.4 | – | 0 | 3.3 |
| Kwon et al, 201014 | 132 | 58 | – | MRA at 6 mo | 6 | 5 | – | 0 | 0 |
| Park et al, 200313 | 73 | 72.6 | 87.8 | Angiography at 6 mo | 13.9 | 23.1 | – | 0 | 8.3 |
| Thornton et al, 20009 | 71 | 28.2 | 54 | Angiography at 6 mo | 16 | 16.4 | – | 1 (2) | 5.6 |
Note:—CO indicates complete occlusion; EVT, endovascular treatment; –, not available.